BIOMARK-PSNCT07604883
Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes
StatusEnrolling by Invitation
PhaseNot specified
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
Notable Enrolling by invitation only Show 4 more changesShow less
- Start date: Jun 4, 2026 to Oct 30, 2026
- Eligibility criteria revised
- Site contacts updated at 2 of 2 sites
- Publications: details revised at 6 of 6 entries
- Notable Primary endpoint(s) modified
- Eligibility criteria expanded, about 17 words
- Secondary endpoints revised (2)
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Differential expression of selected microRNAs
Timeframe: 18 months
Differences in metabolomic profiles
Timeframe: 18 months
Secondary (2)
Ability of biomarkers to differentiate PD and APS
Changes in molecular (miRNA, metabolomic) profiles over time
Sites
2 sites in 1 country